Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation

Abstract

Previous studies have shown that lutein can inhibit the proliferation of breast cancer cells. However, the mecha‑ nism of lutein inhibiting the proliferation of breast cancer cells remains unclear. The present study aimed to determine whether the long non‑coding RNA (lncRNA) Cancer Susceptibility 9 (CASC9)/microRNA (miR)‑590‑3p axis participates in the antiproliferative effects of lutein via lncRNA microarray hybridization, reverse transcription‑quantitative PCR, dual‑luciferase reporter and MTT assays. The results demon‑ strated that CASC9 was the most significantly downregulated lncRNA in MCF7 cells treated with lutein. miR‑590‑3p was identified as the target of CASC9. In addition, lutein down‑ regulated CASC9 expression and upregulated miR‑590‑3p expression in dose‑ and time‑dependent manners, respectively. CASC9 knockdown or overexpression of miR‑590‑3p inhibited the proliferation of breast cancer cells. Notably, simultaneous transfection with miR‑590‑3p mimics and CASC9 small interfering RNA increased the potency of lutein in inhibiting the proliferation of breast cancer cells. Taken together, these results suggest that the CASC9/miR‑590‑3p axis participates in the antiproliferative effects of lutein on breast cancer.